{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-22-008716","form_type":"8-K","ticker":"SNOA","cik":"0001367083","company_name":"Sonoma Pharmaceuticals, Inc.","filed_at":"2022-12-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.336879+00:00","generated_at":"2026-06-20T21:22:19.584925+00:00","sec_items":["5.02","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Sonoma Pharmaceuticals grants annual options to execs and directors at $1.08 strike","bullets":["Board revised Director Compensation Plan, reducing annual director option grants to 20,000 per director.","CEO Amy Trombly awarded 40,000 options; COO Bruce Thornton 40,000; CFO Chad White 9,753 (prorated).","Exercise price $1.08 per share; options vest in three equal annual tranches over three years.","Options accelerate on change of control and as provided in executive employment agreements."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-22-008716","json":"https://secwatch.observer/filing/0001683168-22-008716.json","markdown":"https://secwatch.observer/filing/0001683168-22-008716.md","text":"https://secwatch.observer/filing/0001683168-22-008716.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1367083/000168316822008716/0001683168-22-008716-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1367083/000168316822008716/sonoma_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T21:22:19.584925+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}